Global Cell Based Immunotherapy Market Share

Statistics for the 2023 & 2024 Global Cell Based Immunotherapy market share, created by Mordor Intelligence™ Industry Reports. Global Cell Based Immunotherapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Immune System Drugs Research Immunodeficiencies Research Cell-based Immunotherapies Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Cell Based Immunotherapy Industry

The cell-based immunotherapy market is consolidated, moderately competitive, and has a few major players. The companies currently dominating the market are Novartis AG, Gilead Sciences, Inc (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co., Ltd, and GC Biopharma Corporation.

Cell-Based Immunotherapy Market Leaders

  1. Novartis AG

  2. Gilead Sciences, Inc (Kite Pharma)

  3. Dendreon Pharmaceuticals LLC

  4. JW CreaGene Co., Ltd

  5. GC Biopharma Corporation

*Disclaimer: Major Players sorted in no particular order

cell based.png

Cell Based Immunotherapy Market Report Snapshots

Cell Based Immunotherapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)